Michael S. Cuffe - 31 Jan 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
EVP and Chief Clinical Officer
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
31 Jan 2024
Transactions value $
-$981,734
Form type
4
Filing time
02 Feb 2024, 18:38:03 UTC
Previous filing
02 May 2023
Next filing
21 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Gift $0 -728 -2.52% $0.00 28.1K 31 Jan 2024 Direct F1
transaction HCA Common Stock Sale -$982K -3.2K -11.38% $306.79 24.9K 31 Jan 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Award $0 +12.7K $0.00 12.7K 31 Jan 2024 Common Stock 12.7K $304.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 2,436.9672 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
F2 The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.